CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Philip L. De Jager(Broad Institute), David A. Bennett(Rush University Medical Center), Lori B. Chibnik(Harvard University), Brendan T Keenan(University of Pennsylvania), Julie A. Schneider(Rush University Medical Center), Elizabeth M. Bradshaw(Broad Institute), Alina Von Korff(Brigham and Women's Hospital), Selina Imboywa(Broad Institute), Martha Clare Morris(Rush University Medical Center), Towfique Raj(Icahn School of Medicine at Mount Sinai), Linda Ottoboni(Brigham and Women's Hospital), Keith A. Johnson(Brigham and Women's Hospital), Michelle Lee(Massachusetts General Hospital), Laura Rosenkrantz(Broad Institute), Anna Tang(Broad Institute), Reisa A. Sperling(Harvard University), Denis A. Evans(Rush University Medical Center)
Cited by 602
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k